Fig. 1From: Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeuticsHMGB1/RAGE/TLR4 pathway signaling. RAGE; receptor for advanced glycation end products, TLR4; toll like receptor 4, NF-kB; nuclear factor kappa B, NMDA; N-methyl-D-aspartic acidBack to article page